Although it is debatable whether Helicobacter pylori may play a role in the
pathogenesis of rosacea, some authors suggested that the treatment of H. p
ylori might have a beneficial effect. The aim of this investigation was to
compare the prevalence of H. pylori between rosacea patients and controls,
and to evaluate an effect of H. pylori eradication on rosecea by a e-week t
riple therapy that was composed of amoxicillin, clarithromycin and omeprazo
le. H. pylori was detected by using gastroscopic biopsy with Warthin- Starr
y stain. Forty-two (84%) of 50 patients with rosacea and 39 (78%) of 50 con
trols had H. pylori, showing no significant difference in prevalence. The c
ure rates of H. pylori in rosacea patients and controls were 80% (16/20) an
d 85% (17/20), respectively. There was no significant decrease in the inten
sity of erythema in active treatment and placebo groups both during and aft
er the treatment. Temporary improvement in papulopustules exclusively durin
g the treatment (within 2 weeks) could be independent of H. pylori eradicat
ion. Overall, no significant reduction in the number of papulopustules was
observed in active treatment and placebo groups after the treatment (in 2 m
onths). Taken together, our study found no significant lessening of rosacea
lesions by treating H. pylori infection, which conclusively does not concu
r with a view that H. pylori may be related to rosacea.